Moreover, Halle et al [18] found that HER2 genomic alterations rather than protein overexpression were associated with poor disease‐specific survival in patients with cervical carcinoma despite the presence of a link between gene copy number and protein status. The gene discussed is ERBB2; the disease is cervical carcinoma.